Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC)
Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC)
Enrolling by invitation · NCT06950190 · Registry updated 2025-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC) | Chemically-Induced Disorders, Chemotherapy-Related Cognitive Impairment, Cognition Disorders, Cognitive Dysfunction, Drug-Related Side Effects and Adverse Reactions, cognitive disorder, nervous system disorder, poisoning, psychiatric disorder, toxic encephalopathy | Enrolling by invitation | Phase 3 | 2025-08-12 | NCT06950190 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ellis Medicine | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ellis Medicine/Roswell Park Medical Oncology | Schenectady | United States | 2 |